Nitric Oxide and the Cardiovascular System
Interest in nitric oxide biology has greatly intensified over the past decade in concert with our increasing appreciation of its many roles in the cardiovascular systems. In Nitric Oxide and the Cardiovascular System, world leaders in the field comprehens
- PDF / 7,252,217 Bytes
- 589 Pages / 504.567 x 720 pts Page_size
- 2 Downloads / 231 Views
CONTEMPORARY CARDIOLOGY Christopher P. Cannon, Series Editor Management of Acute Coronary Syndromes, edited by Christopher P. Cannon, 1999 Minimally Invasive Cardiac Surgery, edited by Mehmet C. Oz and Daniel J. Goldstein, 1999 Annotated Atlas of Electrocardiography: A Guide to Confident Interpretation edited by Thomas M. Blake, 1999 Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease, edited by A. Michael Lincoff and Eric J. Topol, 1999 Nitric Oxide and the Cardiovascular System, edited by Joseph Loscalzo and Joseph A. Vita, 2000
NITRIC OXIDE AND THE CARDIOVASCULAR SYSTEM Edited by
JOSEPH LOSCALZO, MD, PHD JOSEPH A. VITA, MD Boston University Medical Center, Boston, MA
SPRINGER SCIENCE+BUSINESS MEDIA, LLC
© 2000 Springer Science+Business Media New York Originally published by Humana Press Inc in 2000 Softcover reprint of the hardcover 1st edition 2000
All rights reserved. No part of this book may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, microfilming, recording, or otherwise without written permission from the Publisher. All articles, comments, opinions, conclusions, or recommendations are those of the author(s), and do not necessarily reflect the views of the publisher. Due diligence has been taken by the publishers, editors, and authors of this book to assure the accuracy of the information published and to describe generally accepted practices. The contributors herein have carefully checked to ensure that the drug selections and dosages set forth in this text are accurate and in accord with the standards accepted at the time of publication. Notwithstanding, as new research, changes in government regulations, and knowledge from clinical experience relating to drug therapy and drug reactions constantly occurs, the reader is advised to check the product information provided by the manufacturer of each drug for any change in dosages or for additional warnings and contraindications. This is of utmost importance when the recommended drug herein is a new or infrequently used drug. It is the responsibility of the treating physician to determine dosages and treatment strategies for individual patients. Further it is the responsibility of the health care provider to ascertain the Food and Drug Administration status of each drug or device used in their clinical practice. The publisher, editors, and authors are not responsible for errors or omissions or for any consequences from the application of the information presented in this book and make no warranty, express or implied, with respect to the contents in this publication. ISBN 978-1-61737-101-1
ISBN 978-1-59259-002-5 (eBook)
DOI 10.1007/978-1-59259-002-5 Cover design by Patricia F. Cleary. This publication is printed on acid-free paper. ∞ ANSI Z39.48-1984 (American National Standards Institute) Permanence of Paper for Printed Library Materials. Photocopy Authorization Policy: Authorization to photocopy items for internal or personal use, Springer Science+Busin
Data Loading...
